User profiles for Vivek Naranbai
 | A/Prof Vivek NaranbhaiMonash University Verified email at monash.edu Cited by 8000 |
[PDF][PDF] mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
…, MC Poznansky, AG Schmidt, AJ Iafrate, V Naranbhai… - Cell, 2022 - cell.com
Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529)
harboring up to 36 mutations in spike protein, the target of neutralizing antibodies…
harboring up to 36 mutations in spike protein, the target of neutralizing antibodies…
[HTML][HTML] Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However,
ongoing surveillance has revealed the emergence of variants harboring mutations in …
ongoing surveillance has revealed the emergence of variants harboring mutations in …
[HTML][HTML] A systematic review of definitions of extreme phenotypes of HIV control and progression
The study of individuals at opposite ends of the HIV clinical spectrum can provide invaluable
insights into HIV biology. Heterogeneity in criteria used to define these individuals can …
insights into HIV biology. Heterogeneity in criteria used to define these individuals can …
Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression
Introduction Many genetic variants associated with common disease susceptibility occur
close to immune-related genes in noncoding DNA, suggestive of a regulatory function. The …
close to immune-related genes in noncoding DNA, suggestive of a regulatory function. The …
[PDF][PDF] T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
The SARS-CoV-2 Omicron variant (B.1.1.529) contains mutations that mediate escape from
antibody responses, although the extent to which these substitutions in spike and non-spike …
antibody responses, although the extent to which these substitutions in spike and non-spike …
[HTML][HTML] Host genetic variation and HIV disease: from mapping to mechanism
V Naranbhai, M Carrington - Immunogenetics, 2017 - Springer
This review aims to provide a summary of current knowledge of host genetic effects on
human immunodeficiency virus (HIV) disease. Mapping of simple single nucleotide …
human immunodeficiency virus (HIV) disease. Mapping of simple single nucleotide …
Genital inflammation and the risk of HIV acquisition in women
…, F Little, LE Mansoor, V Naranbhai… - Clinical Infectious …, 2015 - academic.oup.com
Background. Women in Africa, especially young women, have very high human immunodeficiency
virus (HIV) incidence rates that cannot be fully explained by behavioral risks. We …
virus (HIV) incidence rates that cannot be fully explained by behavioral risks. We …
[HTML][HTML] Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Anti-PD-1/PD-L1 agents have transformed the treatment landscape of advanced non-small
cell lung cancer (NSCLC). To expand our understanding of the molecular features underlying …
cell lung cancer (NSCLC). To expand our understanding of the molecular features underlying …
Germline variants associated with toxicity to immune checkpoint blockade
Immune checkpoint inhibitors (ICIs) have yielded remarkable responses but often lead to
immune-related adverse events (irAEs). Although germline causes for irAEs have been …
immune-related adverse events (irAEs). Although germline causes for irAEs have been …
[HTML][HTML] T-cell activation is an immune correlate of risk in BCG vaccinated infants
…, ZR Manjaly-Thomas, V Naranbhai… - Nature …, 2016 - nature.com
Vaccines to protect against tuberculosis (TB) are urgently needed. We performed a case–control
analysis to identify immune correlates of TB disease risk in Bacille Calmette–Guerin (…
analysis to identify immune correlates of TB disease risk in Bacille Calmette–Guerin (…
